English
简体中文
Total: £ 56.28
Published Date: 2026-01-23 | Pages: 122 | Tables: 126 | Medical Care
The global GalNac Conjugates market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on GalNac Conjugates competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
GalNAc is a ligand for the asialoglycoprotein receptor (ASGPR), which is an endocytic receptor highly specifically expressed on the surface of liver cells, with minimal expression in other cell types.GalNAc conjugated with peptides or oligonucleotides (including siRNA and ASO) has broad application prospects in the biomedical field.The development of GalNAc oligonucleotide conjugates for the targeted delivery of RNA interference therapeutics to liver enabled great advances in the oligonucleotide potency. With the successful translation in human clinical trials, this strategy has been widely adopted for a variety of nucleic acid therapeutics, including ASOs and anti-microRNAs (anti-miRs). The GalNAc peptide conjugate is one of the most fascinating types of therapeutic entities in the domain of pharmacology. It consists of a peptide or protein drug that is intricately connected to a GalNAc (N-acetylgalactosamine) molecule, forming a remarkable hybrid structure. This complex architecture aims to enhance the selectivity and transport of the therapeutic agent to desired cellular and tissue sites while simultaneously mitigating the danger of non-specific, off-target effects.
The North American market for GalNac Conjugates is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for GalNac Conjugates is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
Major global manufacturers of GalNac Conjugates include WuXi AppTec, BOCSCI Inc., Creative Biogene, Creative Biolabs, Biosynthesis, LGC Biosearch Technologies, Sinopep, Organix, CD Formulation, Maravai LifeSciences (Glen Research), etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global GalNac Conjugates market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding GalNac Conjugates. The GalNac Conjugates market size, estimates, and forecasts are provided in terms of sales volume (Kg) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global GalNac Conjugates market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist GalNac Conjugates manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
WuXi AppTec
BOCSCI Inc.
Creative Biogene
Creative Biolabs
Biosynthesis
LGC Biosearch Technologies
Sinopep
Organix
CD Formulation
Maravai LifeSciences (Glen Research)
HitGen
LifeTein LLC
Creative Peptides
Suzhou Biosyntech
Segment by Type
GalNac siRNA Conjugate
GalNac ASO Conjugate
GalNac Peptide Conjugate
by Application
Genetic Disorders
Viral Infections
Cancer
Other
Consumption by Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for GalNac Conjugates manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines GalNac Conjugates sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 GalNac Conjugates Market Overview
1.1 Product Definition
1.2 GalNac Conjugates by Type
1.2.1 Global GalNac Conjugates Market Value by Type: 2025 vs 2032
1.2.2 GalNac siRNA Conjugate
1.2.3 GalNac ASO Conjugate
1.2.4 GalNac Peptide Conjugate
1.3 GalNac Conjugates by Application
1.3.1 Global GalNac Conjugates Market Value by Application: 2025 vs 2032
1.3.2 Genetic Disorders
1.3.3 Viral Infections
1.3.4 Cancer
1.3.5 Other
1.4 Global GalNac Conjugates Market Size Estimates and Forecasts
1.4.1 Global GalNac Conjugates Revenue 2021–2032
1.4.2 Global GalNac Conjugates Sales 2021–2032
1.4.3 Global GalNac Conjugates Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 GalNac Conjugates Market Competition by Manufacturers
2.1 Global GalNac Conjugates Sales Market Share by Manufacturers (2021–2026)
2.2 Global GalNac Conjugates Revenue Market Share by Manufacturers (2021–2026)
2.3 Global GalNac Conjugates Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of GalNac Conjugates, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of GalNac Conjugates, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of GalNac Conjugates, Product Types and Applications
2.7 Global Key Manufacturers of GalNac Conjugates, Date of Entry into the Industry
2.8 Global GalNac Conjugates Market Competitive Situation and Trends
2.8.1 Global GalNac Conjugates Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global GalNac Conjugates Players Market Share by Revenue
2.8.3 Global GalNac Conjugates Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global GalNac Conjugates Market Scenario by Region
3.1 Global GalNac Conjugates Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global GalNac Conjugates Sales by Region: 2021–2032
3.2.1 Global GalNac Conjugates Sales by Region: 2021–2026
3.2.2 Global GalNac Conjugates Sales by Region: 2027–2032
3.3 Global GalNac Conjugates Revenue by Region: 2021–2032
3.3.1 Global GalNac Conjugates Revenue by Region: 2021–2026
3.3.2 Global GalNac Conjugates Revenue by Region: 2027–2032
3.4 North America GalNac Conjugates Market Facts & Figures by Country
3.4.1 North America GalNac Conjugates Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America GalNac Conjugates Sales by Country (2021–2032)
3.4.3 North America GalNac Conjugates Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe GalNac Conjugates Market Facts & Figures by Country
3.5.1 Europe GalNac Conjugates Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe GalNac Conjugates Sales by Country (2021–2032)
3.5.3 Europe GalNac Conjugates Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific GalNac Conjugates Market Facts & Figures by Region
3.6.1 Asia Pacific GalNac Conjugates Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific GalNac Conjugates Sales by Region (2021–2032)
3.6.3 Asia Pacific GalNac Conjugates Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America GalNac Conjugates Market Facts & Figures by Country
3.7.1 Latin America GalNac Conjugates Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America GalNac Conjugates Sales by Country (2021–2032)
3.7.3 Latin America GalNac Conjugates Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa GalNac Conjugates Market Facts & Figures by Country
3.8.1 Middle East and Africa GalNac Conjugates Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa GalNac Conjugates Sales by Country (2021–2032)
3.8.3 Middle East and Africa GalNac Conjugates Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global GalNac Conjugates Sales by Type (2021–2032)
4.1.1 Global GalNac Conjugates Sales by Type (2021–2026)
4.1.2 Global GalNac Conjugates Sales by Type (2027–2032)
4.1.3 Global GalNac Conjugates Sales Market Share by Type (2021–2032)
4.2 Global GalNac Conjugates Revenue by Type (2021–2032)
4.2.1 Global GalNac Conjugates Revenue by Type (2021–2026)
4.2.2 Global GalNac Conjugates Revenue by Type (2027–2032)
4.2.3 Global GalNac Conjugates Revenue Market Share by Type (2021–2032)
4.3 Global GalNac Conjugates Price by Type (2021–2032)
5 Segment by Application
5.1 Global GalNac Conjugates Sales by Application (2021–2032)
5.1.1 Global GalNac Conjugates Sales by Application (2021–2026)
5.1.2 Global GalNac Conjugates Sales by Application (2027–2032)
5.1.3 Global GalNac Conjugates Sales Market Share by Application (2021–2032)
5.2 Global GalNac Conjugates Revenue by Application (2021–2032)
5.2.1 Global GalNac Conjugates Revenue by Application (2021–2026)
5.2.2 Global GalNac Conjugates Revenue by Application (2027–2032)
5.2.3 Global GalNac Conjugates Revenue Market Share by Application (2021–2032)
5.3 Global GalNac Conjugates Price by Application (2021–2032)
6 Key Companies Profiled
6.1 WuXi AppTec
6.1.1 WuXi AppTec Company Information
6.1.2 WuXi AppTec Description and Business Overview
6.1.3 WuXi AppTec GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 WuXi AppTec GalNac Conjugates Product Portfolio
6.1.5 WuXi AppTec Recent Developments/Updates
6.2 BOCSCI Inc.
6.2.1 BOCSCI Inc. Company Information
6.2.2 BOCSCI Inc. Description and Business Overview
6.2.3 BOCSCI Inc. GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 BOCSCI Inc. GalNac Conjugates Product Portfolio
6.2.5 BOCSCI Inc. Recent Developments/Updates
6.3 Creative Biogene
6.3.1 Creative Biogene Company Information
6.3.2 Creative Biogene Description and Business Overview
6.3.3 Creative Biogene GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Creative Biogene GalNac Conjugates Product Portfolio
6.3.5 Creative Biogene Recent Developments/Updates
6.4 Creative Biolabs
6.4.1 Creative Biolabs Company Information
6.4.2 Creative Biolabs Description and Business Overview
6.4.3 Creative Biolabs GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Creative Biolabs GalNac Conjugates Product Portfolio
6.4.5 Creative Biolabs Recent Developments/Updates
6.5 Biosynthesis
6.5.1 Biosynthesis Company Information
6.5.2 Biosynthesis Description and Business Overview
6.5.3 Biosynthesis GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Biosynthesis GalNac Conjugates Product Portfolio
6.5.5 Biosynthesis Recent Developments/Updates
6.6 LGC Biosearch Technologies
6.6.1 LGC Biosearch Technologies Company Information
6.6.2 LGC Biosearch Technologies Description and Business Overview
6.6.3 LGC Biosearch Technologies GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 LGC Biosearch Technologies GalNac Conjugates Product Portfolio
6.6.5 LGC Biosearch Technologies Recent Developments/Updates
6.7 Sinopep
6.7.1 Sinopep Company Information
6.7.2 Sinopep Description and Business Overview
6.7.3 Sinopep GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Sinopep GalNac Conjugates Product Portfolio
6.7.5 Sinopep Recent Developments/Updates
6.8 Organix
6.8.1 Organix Company Information
6.8.2 Organix Description and Business Overview
6.8.3 Organix GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Organix GalNac Conjugates Product Portfolio
6.8.5 Organix Recent Developments/Updates
6.9 CD Formulation
6.9.1 CD Formulation Company Information
6.9.2 CD Formulation Description and Business Overview
6.9.3 CD Formulation GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 CD Formulation GalNac Conjugates Product Portfolio
6.9.5 CD Formulation Recent Developments/Updates
6.10 Maravai LifeSciences (Glen Research)
6.10.1 Maravai LifeSciences (Glen Research) Company Information
6.10.2 Maravai LifeSciences (Glen Research) Description and Business Overview
6.10.3 Maravai LifeSciences (Glen Research) GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Maravai LifeSciences (Glen Research) GalNac Conjugates Product Portfolio
6.10.5 Maravai LifeSciences (Glen Research) Recent Developments/Updates
6.11 HitGen
6.11.1 HitGen Company Information
6.11.2 HitGen Description and Business Overview
6.11.3 HitGen GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 HitGen GalNac Conjugates Product Portfolio
6.11.5 HitGen Recent Developments/Updates
6.12 LifeTein LLC
6.12.1 LifeTein LLC Company Information
6.12.2 LifeTein LLC Description and Business Overview
6.12.3 LifeTein LLC GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 LifeTein LLC GalNac Conjugates Product Portfolio
6.12.5 LifeTein LLC Recent Developments/Updates
6.13 Creative Peptides
6.13.1 Creative Peptides Company Information
6.13.2 Creative Peptides Description and Business Overview
6.13.3 Creative Peptides GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Creative Peptides GalNac Conjugates Product Portfolio
6.13.5 Creative Peptides Recent Developments/Updates
6.14 Suzhou Biosyntech
6.14.1 Suzhou Biosyntech Company Information
6.14.2 Suzhou Biosyntech Description and Business Overview
6.14.3 Suzhou Biosyntech GalNac Conjugates Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 Suzhou Biosyntech GalNac Conjugates Product Portfolio
6.14.5 Suzhou Biosyntech Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 GalNac Conjugates Industry Chain Analysis
7.2 GalNac Conjugates Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 GalNac Conjugates Production Mode & Process Analysis
7.4 GalNac Conjugates Sales and Marketing
7.4.1 GalNac Conjugates Sales Channels
7.4.2 GalNac Conjugates Distributors
7.5 GalNac Conjugates Customer Analysis
8 GalNac Conjugates Market Dynamics
8.1 GalNac Conjugates Industry Trends
8.2 GalNac Conjugates Market Drivers
8.3 GalNac Conjugates Market Challenges
8.4 GalNac Conjugates Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global GalNac Conjugates Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global GalNac Conjugates Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global GalNac Conjugates Market Competitive Situation by Manufacturers in 2025
Table 4. Global GalNac Conjugates Sales (Kg) of Key Manufacturers (2021–2026)
Table 5. Global GalNac Conjugates Sales Market Share by Manufacturers (2021–2026)
Table 6. Global GalNac Conjugates Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global GalNac Conjugates Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market GalNac Conjugates Average Price (US$/g) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of GalNac Conjugates, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of GalNac Conjugates, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of GalNac Conjugates, Product Types and Applications
Table 12. Global Key Manufacturers of GalNac Conjugates, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global GalNac Conjugates Companies by Tier (Tier 1, Tier 2, Tier 3), based on GalNac Conjugates Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global GalNac Conjugates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global GalNac Conjugates Sales by Region (Kg), 2021–2026
Table 18. Global GalNac Conjugates Sales Market Share by Region (2021–2026)
Table 19. Global GalNac Conjugates Sales by Region (Kg), 2027–2032
Table 20. Global GalNac Conjugates Sales Market Share by Region (2027–2032)
Table 21. Global GalNac Conjugates Revenue by Region (US$ Million), 2021–2026
Table 22. Global GalNac Conjugates Revenue Market Share by Region (2021–2026)
Table 23. Global GalNac Conjugates Revenue by Region (US$ Million), 2027–2032
Table 24. Global GalNac Conjugates Revenue Market Share by Region (2027–2032)
Table 25. North America GalNac Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America GalNac Conjugates Sales by Country (Kg), 2021–2026
Table 27. North America GalNac Conjugates Sales by Country (Kg), 2027–2032
Table 28. North America GalNac Conjugates Revenue by Country (US$ Million), 2021–2026
Table 29. North America GalNac Conjugates Revenue by Country (US$ Million), 2027–2032
Table 30. Europe GalNac Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe GalNac Conjugates Sales by Country (Kg), 2021–2026
Table 32. Europe GalNac Conjugates Sales by Country (Kg), 2027–2032
Table 33. Europe GalNac Conjugates Revenue by Country (US$ Million), 2021–2026
Table 34. Europe GalNac Conjugates Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific GalNac Conjugates Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific GalNac Conjugates Sales by Region (Kg), 2021–2026
Table 37. Asia Pacific GalNac Conjugates Sales by Region (Kg), 2027–2032
Table 38. Asia Pacific GalNac Conjugates Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific GalNac Conjugates Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America GalNac Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America GalNac Conjugates Sales by Country (Kg), 2021–2026
Table 42. Latin America GalNac Conjugates Sales by Country (Kg), 2027–2032
Table 43. Latin America GalNac Conjugates Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America GalNac Conjugates Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa GalNac Conjugates Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa GalNac Conjugates Sales by Country (Kg), 2021–2026
Table 47. Middle East and Africa GalNac Conjugates Sales by Country (Kg), 2027–2032
Table 48. Middle East and Africa GalNac Conjugates Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa GalNac Conjugates Revenue by Country (US$ Million), 2027–2032
Table 50. Global GalNac Conjugates Sales (Kg) by Type (2021–2026)
Table 51. Global GalNac Conjugates Sales (Kg) by Type (2027–2032)
Table 52. Global GalNac Conjugates Sales Market Share by Type (2021–2026)
Table 53. Global GalNac Conjugates Sales Market Share by Type (2027–2032)
Table 54. Global GalNac Conjugates Revenue (US$ Million) by Type (2021–2026)
Table 55. Global GalNac Conjugates Revenue (US$ Million) by Type (2027–2032)
Table 56. Global GalNac Conjugates Revenue Market Share by Type (2021–2026)
Table 57. Global GalNac Conjugates Revenue Market Share by Type (2027–2032)
Table 58. Global GalNac Conjugates Price (US$/g) by Type (2021–2026)
Table 59. Global GalNac Conjugates Price (US$/g) by Type (2027–2032)
Table 60. Global GalNac Conjugates Sales (Kg) by Application (2021–2026)
Table 61. Global GalNac Conjugates Sales (Kg) by Application (2027–2032)
Table 62. Global GalNac Conjugates Sales Market Share by Application (2021–2026)
Table 63. Global GalNac Conjugates Sales Market Share by Application (2027–2032)
Table 64. Global GalNac Conjugates Revenue (US$ Million) by Application (2021–2026)
Table 65. Global GalNac Conjugates Revenue (US$ Million) by Application (2027–2032)
Table 66. Global GalNac Conjugates Revenue Market Share by Application (2021–2026)
Table 67. Global GalNac Conjugates Revenue Market Share by Application (2027–2032)
Table 68. Global GalNac Conjugates Price (US$/g) by Application (2021–2026)
Table 69. Global GalNac Conjugates Price (US$/g) by Application (2027–2032)
Table 70. WuXi AppTec Company Information
Table 71. WuXi AppTec Description and Business Overview
Table 72. WuXi AppTec GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 73. WuXi AppTec GalNac Conjugates Product
Table 74. WuXi AppTec Recent Developments/Updates
Table 75. BOCSCI Inc. Company Information
Table 76. BOCSCI Inc. Description and Business Overview
Table 77. BOCSCI Inc. GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 78. BOCSCI Inc. GalNac Conjugates Product
Table 79. BOCSCI Inc. Recent Developments/Updates
Table 80. Creative Biogene Company Information
Table 81. Creative Biogene Description and Business Overview
Table 82. Creative Biogene GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 83. Creative Biogene GalNac Conjugates Product
Table 84. Creative Biogene Recent Developments/Updates
Table 85. Creative Biolabs Company Information
Table 86. Creative Biolabs Description and Business Overview
Table 87. Creative Biolabs GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 88. Creative Biolabs GalNac Conjugates Product
Table 89. Creative Biolabs Recent Developments/Updates
Table 90. Biosynthesis Company Information
Table 91. Biosynthesis Description and Business Overview
Table 92. Biosynthesis GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 93. Biosynthesis GalNac Conjugates Product
Table 94. Biosynthesis Recent Developments/Updates
Table 95. LGC Biosearch Technologies Company Information
Table 96. LGC Biosearch Technologies Description and Business Overview
Table 97. LGC Biosearch Technologies GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 98. LGC Biosearch Technologies GalNac Conjugates Product
Table 99. LGC Biosearch Technologies Recent Developments/Updates
Table 100. Sinopep Company Information
Table 101. Sinopep Description and Business Overview
Table 102. Sinopep GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 103. Sinopep GalNac Conjugates Product
Table 104. Sinopep Recent Developments/Updates
Table 105. Organix Company Information
Table 106. Organix Description and Business Overview
Table 107. Organix GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 108. Organix GalNac Conjugates Product
Table 109. Organix Recent Developments/Updates
Table 110. CD Formulation Company Information
Table 111. CD Formulation Description and Business Overview
Table 112. CD Formulation GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 113. CD Formulation GalNac Conjugates Product
Table 114. CD Formulation Recent Developments/Updates
Table 115. Maravai LifeSciences (Glen Research) Company Information
Table 116. Maravai LifeSciences (Glen Research) Description and Business Overview
Table 117. Maravai LifeSciences (Glen Research) GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 118. Maravai LifeSciences (Glen Research) GalNac Conjugates Product
Table 119. Maravai LifeSciences (Glen Research) Recent Developments/Updates
Table 120. HitGen Company Information
Table 121. HitGen Description and Business Overview
Table 122. HitGen GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 123. HitGen GalNac Conjugates Product
Table 124. HitGen Recent Developments/Updates
Table 125. LifeTein LLC Company Information
Table 126. LifeTein LLC Description and Business Overview
Table 127. LifeTein LLC GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 128. LifeTein LLC GalNac Conjugates Product
Table 129. LifeTein LLC Recent Developments/Updates
Table 130. Creative Peptides Company Information
Table 131. Creative Peptides Description and Business Overview
Table 132. Creative Peptides GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 133. Creative Peptides GalNac Conjugates Product
Table 134. Creative Peptides Recent Developments/Updates
Table 135. Suzhou Biosyntech Company Information
Table 136. Suzhou Biosyntech Description and Business Overview
Table 137. Suzhou Biosyntech GalNac Conjugates Sales (Kg), Revenue (US$ Million), Price (US$/g), and Gross Margin (2021–2026)
Table 138. Suzhou Biosyntech GalNac Conjugates Product
Table 139. Suzhou Biosyntech Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. GalNac Conjugates Distributors List
Table 143. GalNac Conjugates Customers List
Table 144. GalNac Conjugates Market Trends
Table 145. GalNac Conjugates Market Drivers
Table 146. GalNac Conjugates Market Challenges
Table 147. GalNac Conjugates Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 151. Authors List of This Report
List of Figures
Figure 1. Product Picture of GalNac Conjugates
Figure 2. Global GalNac Conjugates Market Value by Type (US$ Million), 2021–2032
Figure 3. Global GalNac Conjugates Market Share by Type: 2025 & 2032
Figure 4. GalNac siRNA Conjugate Product Picture
Figure 5. GalNac ASO Conjugate Product Picture
Figure 6. GalNac Peptide Conjugate Product Picture
Figure 7. Global GalNac Conjugates Market Value by Application (US$ Million), 2021–2032
Figure 8. Global GalNac Conjugates Market Share by Application: 2025 & 2032
Figure 9. Genetic Disorders
Figure 10. Viral Infections
Figure 11. Cancer
Figure 12. Other
Figure 13. Global GalNac Conjugates Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global GalNac Conjugates Market Size (US$ Million), 2021–2032
Figure 15. Global GalNac Conjugates Sales (Kg), 2021–2032
Figure 16. Global GalNac Conjugates Average Price (US$/g), 2021–2032
Figure 17. GalNac Conjugates Report Years Considered
Figure 18. GalNac Conjugates Sales Share by Manufacturers in 2025
Figure 19. Global GalNac Conjugates Revenue Share by Manufacturers in 2025
Figure 20. Top 5 and Top 10 Global GalNac Conjugates Players: Market Share by Revenue in GalNac Conjugates in 2025
Figure 21. GalNac Conjugates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 22. Global GalNac Conjugates Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 23. North America GalNac Conjugates Sales Market Share by Country (2021–2032)
Figure 24. North America GalNac Conjugates Revenue Market Share by Country (2021–2032)
Figure 25. United States GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Canada GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 27. Europe GalNac Conjugates Sales Market Share by Country (2021–2032)
Figure 28. Europe GalNac Conjugates Revenue Market Share by Country (2021–2032)
Figure 29. Germany GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. France GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. U.K. GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Italy GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Russia GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 34. Asia Pacific GalNac Conjugates Sales Market Share by Region (2021–2032)
Figure 35. Asia Pacific GalNac Conjugates Revenue Market Share by Region (2021–2032)
Figure 36. China GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. Japan GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. South Korea GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. India GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. Australia GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. China Taiwan GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Southeast Asia GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 43. Latin America GalNac Conjugates Sales Market Share by Country (2021–2032)
Figure 44. Latin America GalNac Conjugates Revenue Market Share by Country (2021–2032)
Figure 45. Mexico GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Brazil GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Argentina GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Colombia GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 49. Middle East and Africa GalNac Conjugates Sales Market Share by Country (2021–2032)
Figure 50. Middle East and Africa GalNac Conjugates Revenue Market Share by Country (2021–2032)
Figure 51. Turkey GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. Saudi Arabia GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. UAE GalNac Conjugates Revenue Growth Rate (US$ Million), 2021–2032
Figure 54. Global Sales Market Share of GalNac Conjugates by Type (2021–2032)
Figure 55. Global Revenue Market Share of GalNac Conjugates by Type (2021–2032)
Figure 56. Global GalNac Conjugates Price (US$/g) by Type (2021–2032)
Figure 57. Global Sales Market Share of GalNac Conjugates by Application (2021–2032)
Figure 58. Global Revenue Market Share of GalNac Conjugates by Application (2021–2032)
Figure 59. Global GalNac Conjugates Price (US$/g) by Application (2021–2032)
Figure 60. GalNac Conjugates Value Chain
Figure 61. Channels of Distribution (Direct Vs Distribution)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
